Stocks Health care FLNA
NASDAQ · Health careFilana Therapeutics, Inc. (FLNA)
It posted a net loss of $77.9M. In fiscal 2025 capital spending exceeded operating cash flow by $32.8M. At March 31, 2026 it held $86.6M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on July 29, 2026.
Key facts about Filana Therapeutics, Inc.
- Net worth
- Filana Therapeutics, Inc. has a market value (market cap) of $24M at the latest share price, and shareholders' equity of $68.1M on its balance sheet at March 31, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Cash flow
- In fiscal 2025 operations used $32.3M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on July 29, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
- Next earnings report
- Filana Therapeutics, Inc.'s next report is expected around November 11, 2026. That is an estimate from its filing rhythm, not a date the company has announced.
What Filana Therapeutics, Inc. does
Filana Therapeutics, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker FLNA.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | n/a | -$91M | -$1.88 | -$32.8M |
| 2024 | n/a | -$24.3M | -$1.46 | -$117M |
| 2023 | n/a | -$97.2M | -$2.32 | -$82.4M |
| 2022 | n/a | -$76.2M | -$1.90 | -$80.2M |
| 2021 | n/a | -$32.4M | -$0.82 | -$52.4M |
| 2020 | n/a | -$6.3M | -$0.24 | n/a |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Latest SEC filings
What Filana Therapeutics, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 22, 2026
- September 18, 2026
- July 29, 2026Quarterly report 10-Q · period to June 30, 2026
- July 29, 2026
- June 15, 2026
- May 7, 2026
- May 7, 2026
- April 28, 2026
- April 28, 2026Proxy statement DEF 14A
- April 28, 2026
Insider trades
What the people running Filana Therapeutics, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders bought $356.3K worth of shares on the open market in the last 90 days and sold none.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| September 30, 2026 | Barry RichardPresident & CEO, Director | Boughtindirect | 100,000 | $92K |
| September 29, 2026 | Barry RichardPresident & CEO, Director | Boughtindirect | 206,813 | $186.1K |
| September 28, 2026 | Barry RichardPresident & CEO, Director | Boughtindirect | 93,091 | $78.2K |
| November 24, 2025 | Anderson Robert Eugene JrDirector | Bought | 8,600 | $24.9K |
| November 20, 2025 | Barry RichardPresident & CEO, Director | Boughtindirect | 150,000 | $414K |
| November 19, 2025 | Barry RichardPresident & CEO, Director | Boughtindirect | 73,385 | $201.8K |
Who owns FLNA
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
Largest institutional holders
Insiders
2 insiders reported holding 1,346,564 shares in total, about $667.9K at the last price.
| Holder | Shares |
|---|---|
| Barry RichardPresident & CEO, Director | 1,337,9641,337,964 held indirectly |
| Anderson Robert Eugene JrDirector | 8,600 |
Questions about FLNA
What does Filana Therapeutics, Inc. do?
Filana Therapeutics, Inc. is a company in the Health care sector, listed on NASDAQ as FLNA. Its shares trade on NASDAQ under the ticker FLNA.
What is Filana Therapeutics, Inc.'s net worth?
Filana Therapeutics, Inc. has a market value (market cap) of $24M at the latest share price, and shareholders' equity of $68.1M on its balance sheet at March 31, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Filana Therapeutics, Inc. profitable?
No. Over the twelve months to March 31, 2026 it reported a net loss of $77.9M.
When did Filana Therapeutics, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on July 29, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from October 1, 2026.
When is Filana Therapeutics, Inc.'s next earnings report?
Filana Therapeutics, Inc.'s next report is expected around November 11, 2026. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare FLNA with
Follow FLNA
Get an email when Filana Therapeutics, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Filana Therapeutics, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.